bezafibrate has been researched along with 2,3-diphosphoglycerate in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (50.00) | 18.7374 |
1990's | 3 (37.50) | 18.2507 |
2000's | 1 (12.50) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Amiconi, G; Ascenzi, P; Bertollini, A; Coletta, M; Desideri, A; Polizio, F; Santucci, R | 1 |
Baklouti, F; Baudin-Chich, V; Delaunay, J; Kister, J; Marden, M; Poyart, C; Teyssier, G; Wajcman, H | 1 |
Bonaventura, C; Bonaventura, J; Cashon, R; Imamura, T; Nagafuchi, S; Sugihara, J | 1 |
Perutz, MF; Poyart, C | 1 |
Wootton, R | 1 |
Kister, J; Marden, MC; Poyart, C | 1 |
Brittain, T; McLennan, AE | 1 |
Fidy, J; Schay, G; Smeller, L; Tsuneshige, A; Yonetani, T | 1 |
1 review(s) available for bezafibrate and 2,3-diphosphoglycerate
Article | Year |
---|---|
Bezafibrate derivatives as potent effectors of hemoglobin.
Topics: 2,3-Diphosphoglycerate; Allosteric Regulation; Allosteric Site; Bezafibrate; Chlorides; Crystallography, X-Ray; Diphosphoglyceric Acids; Drug Synergism; Erythrocyte Membrane; Erythrocytes; Hemoglobins; Humans; Oxygen; Oxyhemoglobins; Protein Binding; Protein Conformation; Serum Albumin; Structure-Activity Relationship | 1994 |
7 other study(ies) available for bezafibrate and 2,3-diphosphoglycerate
Article | Year |
---|---|
Effect of bezafibrate and clofibric acid on the spectroscopic properties of the nitric oxide derivative of ferrous human hemoglobin.
Topics: 2,3-Diphosphoglycerate; Bezafibrate; Clofibric Acid; Diphosphoglyceric Acids; Electron Spin Resonance Spectroscopy; Ferrous Compounds; Hemoglobins; Humans; Molecular Structure; Nitric Oxide; Phytic Acid; Protein Conformation; Spectrophotometry; Spectrum Analysis | 1992 |
Increased oxygen affinity with normal heterotropic effects in hemoglobin Loire [alpha 88(F9)Ala----Ser].
Topics: 2,3-Diphosphoglycerate; Adult; Alanine; Amino Acids; Bezafibrate; Carbon Monoxide; Child; Chromatography, High Pressure Liquid; Diphosphoglyceric Acids; Electrophoresis; Hemoglobin A; Hemoglobins, Abnormal; Humans; Hydrogen-Ion Concentration; Isoelectric Focusing; Kinetics; Macromolecular Substances; Male; Oxygen; Phytic Acid; Serine | 1988 |
Hemoglobin Rahere, a human hemoglobin variant with amino acid substitution at the 2,3-diphosphoglycerate binding site. Functional consequences of the alteration and effects of bezafibrate on the oxygen bindings.
Topics: 2,3-Diphosphoglycerate; Adult; Amino Acids; Bezafibrate; Binding Sites; Blood Protein Electrophoresis; Diphosphoglyceric Acids; Hemoglobins, Abnormal; Humans; Japan; Lysine; Male; Oxygen; Peptides; Polycythemia; Threonine | 1985 |
Bezafibrate lowers oxygen affinity of haemoglobin.
Topics: 2,3-Diphosphoglycerate; Anemia, Sickle Cell; Bezafibrate; Clofibrate; Diphosphoglyceric Acids; Drug Synergism; Erythrocytes; Hemoglobin A; Hemoglobin, Sickle; Humans; Oxygen; Solubility | 1983 |
Analysis of the effect of bezafibrate on the oxygen dissociation curve of human hemoglobin.
Topics: 2,3-Diphosphoglycerate; Bezafibrate; Binding Sites; Binding, Competitive; Diphosphoglyceric Acids; Hemoglobins; Humans; Oxygen | 1984 |
Non-synergistic interactions between strong allosteric effectors and human embryonic and adult haemoglobins.
Topics: 2,3-Diphosphoglycerate; Allosteric Regulation; Amino Acids; Bezafibrate; Binding Sites; Drug Synergism; Fetal Hemoglobin; Globins; Hemoglobins; Humans; Protein Binding | 1998 |
Allosteric effectors influence the tetramer stability of both R- and T-states of hemoglobin A.
Topics: 2,3-Diphosphoglycerate; Allosteric Regulation; Animals; Bezafibrate; Binding Sites; Chlorides; Dimerization; Hemoglobin A; Horses; Humans; Hypolipidemic Agents; Models, Molecular; Myoglobin; Oxidation-Reduction; Phytic Acid; Porphyrins; Protein Binding; Protein Structure, Quaternary; Spectrometry, Fluorescence; Tryptophan | 2006 |